Detalhe da pesquisa
1.
Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial.
Mol Psychiatry
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38454079
2.
International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators.
Mol Psychiatry
; 27(12): 5096-5112, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36071111
3.
Biometrics: Going 3D.
Sensors (Basel)
; 22(17)2022 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36080821
4.
Behavioral Data Analysis of Robot-Assisted Autism Spectrum Disorder (ASD) Interventions Based on Lattice Computing Techniques.
Sensors (Basel)
; 22(2)2022 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35062582
5.
Omics Data and Data Representations for Deep Learning-Based Predictive Modeling.
Int J Mol Sci
; 23(20)2022 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36293133
6.
Success and efficiency of phase 2/3 adjunctive trials for MDD funded by industry: a systematic review.
Mol Psychiatry
; 25(9): 1967-1974, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31988433
7.
Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
Mol Psychiatry
; 25(7): 1604, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30617276
8.
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
Mol Psychiatry
; 25(7): 1592-1603, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30283029
9.
Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder.
J Clin Psychopharmacol
; 40(3): 287-292, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32332464
10.
Improvement of sexual functioning during treatment of MDD with adjunctive pimavanserin: A secondary analysis.
Depress Anxiety
; 37(5): 485-495, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32301591
11.
NSI-189 phosphate, a novel neurogenic compound, selectively benefits moderately depressed patients: A post-hoc analysis of a phase 2 study of major depressive disorder.
Ann Clin Psychiatry
; 32(3): 182-196, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32722729
12.
Double-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression.
Ann Clin Psychiatry
; 32(4): 18-26, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33125454
13.
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression.
Depress Anxiety
; 36(3): 235-243, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30597688
14.
Pre-treatment peripheral biomarkers associated with treatment response in panic symptoms in patients with major depressive disorder and panic disorder: A 12-week follow-up study.
Compr Psychiatry
; 95: 152140, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31669792
15.
Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies.
Int J Neuropsychopharmacol
; 16(8): 1733-44, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23673347
16.
Relationship between sleep disturbance and depression, anxiety, and functioning in college students.
Depress Anxiety
; 30(9): 873-80, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23681944
17.
Pharmacotherapy: Ketamine and Esketamine.
Psychiatr Clin North Am
; 46(2): 277-290, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37149345
18.
Surrogate markers of treatment outcome in major depressive disorder.
Int J Neuropsychopharmacol
; 15(6): 841-54, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21813045
19.
Does the frequency of follow-up assessments affect clinical trial outcome? A meta-analysis and meta-regression of placebo-controlled randomized trials.
Int J Neuropsychopharmacol
; 15(3): 289-96, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21557881
20.
Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.
Ann Pharmacother
; 46(5): 642-9, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22550279